EDAP TMS reported EUR37.39M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
AngioDynamics USD 41.57M 127K Sep/2025
Boston Scientific USD 1.48B 1.46B Jun/2025
EDAP TMS EUR 37.39M 0 Sep/2025
Henry Schein USD 115.77M 2.8M Dec/2025
Medtronic USD 1.28B 1.38M Dec/2025
Plus Therapeutics USD 138.68M 7.07M Dec/2025
Veracyte USD 79.05M 377K Dec/2025